Skip to main content

Advertisement

Fig. 1 | Arthritis Research & Therapy

Fig. 1

From: Baseline metabolic profiles of early rheumatoid arthritis patients achieving sustained drug-free remission after initiating treat-to-target tocilizumab, methotrexate, or the combination: insights from systems biology

Fig. 1

Mean (SE) DAS28-ESR over time in those achieving sDFR (continuous line) vs controls (dotted line) within the three strategy arms. DAS28 disease activity score assessing 28 joints, ESR erythrocyte sedimentation rate, MTX methotrexate, sDFR sustained drug-free remission, SE standard error, TCZ tocilizumab

Back to article page